US stock · Healthcare sector · Biotechnology
Company Logo

Geron Corporation

GERNNASDAQ

2.28

USD
+0.02
(+0.88%)
Market Open
-7.81P/E
-5Forward P/E
-0.39P/E to S&P500
861.427MMarket CAP
- -Div Yield
Scale: |
View:
Currency: USD, in millions
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Income Statement
Revenue
5
7
7
5
7
4
1
1
1
0
3
8
3
2
4
2
3
1
1
36
6
1
1
0
0
0
COGS
(1)
(2)
(2)
(4)
(5)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
7
9
9
9
11
- -
- -
- -
- -
- -
- -
- -
- -
2
4
2
- -
- -
- -
- -
- -
- -
- -
- -
0
- -
Gross Profit Ratio
122.64%
121.92%
125.00%
168.52%
170.40%
- -
- -
- -
- -
- -
- -
- -
- -
100.00%
100.00%
100.00%
- -
- -
- -
- -
- -
- -
- -
- -
10.15%
- -
Operating Expenses
19
20
21
30
37
39
37
31
37
38
51
70
70
72
80
93
72
39
37
36
37
30
32
73
77
0
R&D Expenses
14
15
16
21
24
29
32
26
30
35
41
55
54
58
62
69
51
23
21
18
18
11
13
52
51
0
Selling, G&A Exp.
3
3
4
6
9
10
5
6
7
9
9
16
16
14
18
24
20
16
17
18
19
19
19
21
26
0
General and Admin. Exp.
3
3
4
6
9
10
5
6
7
9
9
16
16
14
18
24
20
16
17
18
19
19
19
21
26
0
Selling and Marketing Exp.
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Expenses
1
2
2
4
5
- -
- -
- -
- -
(6)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
COGS and Expenses
18
18
19
26
33
39
37
31
37
38
51
70
70
72
80
93
72
39
37
36
37
30
32
73
77
- -
Interest Income
- -
- -
- -
- -
6
6
3
2
2
5
9
11
6
1
2
1
3
1
0
1
1
1
3
4
2
0
Interest Expense
0
- -
1
- -
12
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
- -
- -
1
(0)
Depreciation and Amortization
1
2
2
4
5
4
5
4
4
4
2
2
2
2
2
2
1
0
0
0
0
0
0
1
1
- -
EBITDA
(9)
(8)
(8)
(43)
(29)
(37)
(29)
(25)
(76)
(29)
(30)
(35)
(60)
(68)
(110)
(95)
(68)
(38)
(36)
0
(29)
(28)
(27)
(68)
(74)
(0)
EBITDA ratio
(171.70)%
(109.59)%
(120.59)%
(790.74)%
(437.22)%
(1,013.78)%
(2,288.54)%
(2,131.60)%
(7,201.14)%
(10,110.69)%
(904.67)%
(454.80)%
(2,122.94)%
(3,956.43)%
(3,078.02)%
(3,898.11)%
(2,503.43)%
(2,962.04)%
(3,082.48)%
0.52%
(476.68)%
(2,606.85)%
(2,528.89)%
(14,733.04)%
(29,218.18)%
(404.02)%
Operating Income
(12)
(11)
(13)
(21)
(26)
(35)
(36)
(30)
(81)
(38)
(47)
(63)
(67)
(70)
(111)
(96)
(72)
(39)
(36)
(1)
(31)
(29)
(31)
(73)
(77)
(114)
Operating Income ratio
(230.19)%
(149.32)%
(185.29)%
(385.19)%
(396.61)%
(967.38)%
(2,860.58)%
(2,570.70)%
(7,719.37)%
(13,003.45)%
(1,445.22)%
(824.44)%
(2,391.87)%
(4,069.18)%
(3,120.04)%
(3,942.41)%
(2,648.87)%
(3,036.48)%
(3,149.35)%
(1.54)%
(497.34)%
(2,746.95)%
(2,914.92)%
(15,761.96)%
(30,400.40)%
(384,287.88)%
Total Other Income Exp.(Gains)
2
2
3
(23)
- -
(12)
- -
(1)
(45)
6
7
15
(0)
(1)
(37)
(7)
3
1
1
1
1
1
4
4
1
114
Income Before Tax
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(69)
(38)
(36)
0
(30)
(28)
(27)
(69)
(76)
(0)
Income Before Tax ratio
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(2,542.67)%
(2,991.35)%
(3,093.67)%
0.13%
(479.34)%
(2,621.22)%
(2,534.43)%
(14,901.74)%
(29,888.14)%
(391.41)%
Income Tax Expense (Gain)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income
(11)
(10)
(11)
(46)
(46)
(42)
(34)
(30)
(80)
(34)
(31)
(37)
(62)
(70)
(111)
(97)
(69)
(38)
(36)
0
(30)
(28)
(27)
(69)
(76)
(0)
Net Income Ratio
(201.89)%
(131.51)%
(158.82)%
(859.26)%
(693.49)%
(1,162.24)%
(2,716.99)%
(2,545.40)%
(7,635.80)%
(11,561.38)%
(957.13)%
(481.46)%
(2,212.67)%
(4,066.28)%
(3,125.93)%
(3,972.64)%
(2,542.67)%
(2,991.35)%
(3,093.67)%
0.13%
(479.34)%
(2,621.22)%
(2,534.43)%
(14,901.74)%
(29,888.14)%
(391.41)%
EPS
(2.07)
(0.91)
(1.00)
(3.00)
(2.20)
(1.90)
(1.37)
(0.97)
(1.79)
(0.58)
(0.47)
(0.62)
(0.79)
(0.80)
(1.14)
(0.78)
(0.54)
(0.30)
(0.23)
0.00
(0.19)
(0.18)
(0.15)
(0.36)
(0.28)
(0.00)
EPS Diluted
(2.07)
(0.91)
(1.00)
(3.00)
(2.20)
(1.90)
(1.37)
(0.97)
(1.79)
(0.58)
(0.47)
(0.62)
(0.79)
(0.80)
(1.14)
(0.78)
(0.54)
(0.30)
(0.23)
0.00
(0.19)
(0.18)
(0.15)
(0.36)
(0.28)
(0.00)
Weighted Avg. Shares Outs.
5
11
11
15
21
22
25
31
45
58
66
74
78
88
98
125
127
128
154
158
159
159
177
190
271
328
Weighted Avg. Shares Outs. Dil.
8
11
11
15
21
22
25
31
45
58
66
74
78
88
98
125
127
128
154
163
159
159
177
190
271
328
Balance Sheet
Cash and Cash Equivalents
12
4
16
8
30
19
5
13
10
97
136
146
109
35
46
16
22
13
43
21
13
16
11
14
10
35
Short-Term Investments
- -
- -
- -
- -
3
50
42
96
110
94
77
60
53
77
141
105
73
52
109
93
102
78
153
126
186
- -
Cash & Short-Term Investments
12
4
16
8
33
69
47
109
120
190
213
206
163
112
187
121
96
65
151
114
115
95
163
139
196
35
Net Receivables
- -
1
1
1
1
2
1
1
2
2
1
1
1
1
2
1
1
1
1
1
0
0
1
1
1
2
Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Current Assets
13
19
9
32
0
1
3
1
3
3
3
7
5
5
7
3
2
1
1
1
1
1
2
1
3
151
Total Current Assets
25
24
26
40
35
72
51
112
125
196
217
213
168
118
195
126
98
67
153
116
116
96
166
142
200
187
PP&E
3
2
2
4
4
4
2
2
2
3
2
4
4
4
3
1
1
0
0
0
0
0
0
3
6
5
Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Intangible Assets
- -
- -
- -
15
12
10
7
4
1
0
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Goodwill and Intangible Assets
- -
- -
- -
15
12
10
7
4
1
0
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
56
34
32
- -
- -
19
33
14
14
19
20
63
149
Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Non-Current Assets
1
0
16
4
63
11
1
1
4
2
1
1
3
3
1
1
0
0
- -
- -
- -
- -
1
1
2
- -
Total Non-Current Assets
4
3
19
23
79
25
10
6
7
6
4
6
8
63
39
34
1
0
19
33
14
14
19
24
71
154
Other Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
29
26
45
64
114
96
61
118
132
201
221
219
176
180
234
160
100
67
173
149
130
110
185
166
271
341
Accounts Payable
1
1
1
1
1
1
2
1
3
2
2
3
2
2
3
3
3
1
1
0
0
1
1
1
7
7
Short-Term Debt
1
1
1
1
1
1
6
5
3
0
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0
1
51
Tax Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Revenue
- -
- -
- -
- -
- -
1
1
0
0
2
1
0
0
1
0
- -
- -
- -
35
- -
- -
- -
- -
- -
- -
- -
Other Current Liabilities
2
2
2
5
6
7
2
3
3
5
44
10
5
5
37
10
11
6
6
6
8
6
7
27
23
(12)
Total Current Liabilities
4
4
4
8
8
10
9
10
8
9
47
13
8
7
41
13
14
8
42
7
8
7
8
28
31
46
Long-Term Debt
2
1
8
17
32
17
21
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
24
4
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Non-Current Liabilities
- -
- -
- -
13
10
8
1
1
1
1
0
1
0
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
5
50
Total Non-Current Liabilities
2
1
8
30
42
24
22
2
1
1
0
1
0
0
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
29
54
Other Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Lease Obligations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
6
- -
Total Liabilities
5
5
12
38
50
35
31
12
10
11
47
13
8
8
41
13
14
8
42
7
8
7
8
30
60
100
Preferred Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock
- -
- -
- -
- -
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Retained Earnings
(37)
(46)
(58)
(104)
(150)
(192)
(226)
(256)
(336)
(370)
(399)
(445)
(507)
(577)
(689)
(786)
(854)
(893)
(928)
(928)
(958)
(986)
(1,011)
(1,080)
(1,156)
(1,272)
Other Compreh. Income(Loss)
(3)
(4)
(5)
(6)
(7)
(9)
(1)
(1)
(1)
(1)
(0)
0
0
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
0
0
(0)
Other Total Stockhold. Equity
63
71
95
136
221
262
256
363
459
561
573
650
675
750
881
932
940
952
1,059
1,071
1,080
1,090
1,189
1,215
1,366
1,398
Total Stockholders Equity
24
21
33
26
64
62
30
106
122
191
174
206
168
173
193
147
86
60
131
142
122
104
178
135
211
126
Total Liab.&Stockhold. Equity
29
26
45
64
114
96
61
118
132
201
221
219
176
180
234
160
100
67
173
149
130
110
185
166
271
226
Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
115
Total Liabilities & Equity
29
26
45
64
114
96
61
118
132
201
221
219
176
180
234
160
100
67
173
149
130
110
185
166
271
341
Cash Flow Statement
Net Income
(11)
(10)
(11)
(46)
(46)
(42)
(34)
(30)
(80)
(34)
(31)
(37)
(62)
(70)
(111)
(97)
(69)
(38)
(36)
0
(30)
(28)
(27)
(69)
(76)
(0)
Depreciation and Amortization
1
2
2
4
5
4
5
4
4
4
2
2
2
2
2
2
1
0
0
0
0
0
0
1
1
- -
Deferred Income Tax
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Stock Based Compensation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
11
14
15
5
5
8
9
8
8
7
6
7
29
Change in Working Capital
(1)
(2)
1
(1)
(1)
(2)
(4)
(0)
(2)
4
4
10
5
7
9
9
4
(5)
34
(35)
2
(1)
(0)
19
0
11
Accounts Receivable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(0)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0
- -
Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Accounts Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(0)
1
(0)
0
(2)
(0)
(1)
0
0
0
0
6
- -
Other Working Capital
21
20
22
33
(0)
(0)
(0)
102
(0)
186
(0)
0
(2)
1
(1)
(0)
4
(0)
36
(36)
(0)
1
(1)
2
3
(0)
Other Non-Cash Items
0
2
1
30
29
17
2
1
52
5
(1)
(2)
13
8
43
9
3
1
3
2
1
0
(0)
(1)
1
(40)
Cash Provided by Operating Activities
(10)
(8)
(8)
(14)
(14)
(22)
(31)
(24)
(26)
(21)
(26)
(27)
(42)
(43)
(44)
(62)
(55)
(37)
9
(24)
(18)
(21)
(21)
(44)
(67)
- -
CAPEX
(1)
(1)
(1)
(3)
(1)
(1)
(0)
(0)
(2)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
- -
(0)
(0)
(0)
- -
Acquisitions Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0
- -
Purchases of Investments
(25)
(27)
(28)
(31)
(62)
(55)
(32)
(108)
(110)
(129)
(136)
(155)
(78)
(202)
(183)
(145)
(79)
(89)
(190)
(206)
(129)
(100)
(188)
(153)
(313)
- -
Sales/Maturities of Investments
16
22
22
20
32
59
49
54
94
144
154
176
86
121
137
178
141
109
112
207
138
123
111
181
208
- -
Other Investing Activities
- -
(0)
- -
1
- -
- -
- -
- -
- -
- -
- -
(2)
0
0
(1)
(0)
0
1
1
(0)
0
- -
- -
- -
- -
- -
Cash Used for Investing Activities
(10)
(6)
(8)
(13)
(32)
4
17
(55)
(18)
13
17
16
5
(83)
(48)
32
61
21
(78)
0
9
23
(78)
27
(105)
- -
Debt Repayment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(6)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock Issued
20
7
20
1
43
8
0
88
41
95
49
21
0
52
104
0
0
7
98
3
1
1
86
19
144
13,215
Common Stock Repurchased
- -
- -
- -
(4)
- -
- -
- -
- -
- -
- -
- -
- -
(0)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(0)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Financing Activities
0
(1)
7
21
24
(1)
(0)
(0)
(0)
(0)
(0)
- -
- -
- -
- -
6
- -
- -
- -
- -
- -
- -
7
0
24
- -
Cash Used/Provided by Financing Activities
20
6
28
18
67
7
(0)
87
41
94
49
21
(0)
52
104
0
0
7
98
3
1
1
93
19
168
- -
Effect of Forex Changes on Cash
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Change In Cash
- -
- -
- -
(9)
22
(11)
(14)
8
(3)
87
39
10
(37)
(75)
11
(30)
6
(9)
30
(22)
(8)
4
(6)
3
(4)
- -
Cash at the End of Period
- -
- -
- -
8
30
19
5
13
10
97
136
146
109
35
46
16
22
13
43
21
13
16
11
14
10
- -
Cash at the Beginning of Period
13
12
4
16
8
30
19
5
13
10
97
136
146
109
35
46
16
22
13
43
21
13
17
11
14
10
Free Cash Flow
(11)
(9)
(9)
(16)
(15)
(24)
(32)
(25)
(27)
(22)
(27)
(30)
(44)
(45)
(45)
(63)
(56)
(37)
9
(24)
(18)
(21)
(21)
(44)
(67)
- -
Forex Rate
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -